DOI: 10.1111/bjd.15970 , PMID: 28889405 Issn Print: 0007-0963 Publication Date: 2018/01/01 Print Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T‐cell lymphoma D.J. Lewis; Y.H. Kim; M. Duvic + Author Information Author Information: School of Medicine Checking for direct PDF access through Ovid View on Journal Site Abstract Abstract unavailable for this article.
